期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Real-world study on the efficacy and safety of first-line antiviral therapy for chronic hepatitis B
1
作者 常楚笛 《China Medical Abstracts(Internal Medicine)》 2023年第4期226-227,共2页
Objective To clarify the clinical efficacy of first-line oral antiviral drugs tenofovir alafenamide(TAF),tenofovir disoproxil fumarate(TDF),and entecavir(ETV)in the treatment of chronic hepatitis B(CHB)and their safet... Objective To clarify the clinical efficacy of first-line oral antiviral drugs tenofovir alafenamide(TAF),tenofovir disoproxil fumarate(TDF),and entecavir(ETV)in the treatment of chronic hepatitis B(CHB)and their safety profiles with lipid,bone,and kidney metabolism.Methods 458 CHB cases diagnosed and treated at the Department of Hepatology of Integrated Traditional Chinese and Western Medicine of the Third Hospital of Hebei Medical University from February 2010to November 2022 were selected. 展开更多
关键词 DRUGS CLINICAL HEPATITIS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部